Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 444,448 | 408,830 | 276,741 | 240,251 | 231,808 |
| Cost of Goods | 258,555 | 211,994 | 149,476 | 138,295 | 133,704 |
| Gross Profit | 185,893 | 196,836 | 127,265 | 101,956 | 98,104 |
| Operating Expenses | 200,440 | 184,824 | 117,701 | 99,349 | 96,653 |
| Operating Income | -13,992 | 13,006 | 10,040 | 2,902 | 2,155 |
| Interest Expense | 7,019 | 3,713 | 6,230 | 5,540 | 9,998 |
| Other Income | 6,955 | -5,648 | 14 | -12 | 0 |
| Pre-tax Income | -14,056 | 3,645 | 3,824 | -2,650 | -7,843 |
| Income Tax | -18,228 | -4,361 | 1,184 | -2,254 | -1,701 |
| Net Income Continuous | 4,172 | 8,006 | 2,640 | -396 | -6,142 |
| Net Income | $4,172 | $8,006 | $2,640 | $-396 | $-6,142 |
| EPS Basic Total Ops | 0.04 | 0.08 | 0.07 | -0.14 | -0.40 |
| EPS Basic Continuous Ops | 0.04 | 0.08 | 0.03 | -0.01 | -0.08 |
| EPS Diluted Total Ops | 0.04 | 0.08 | 0.07 | -0.14 | -0.40 |
| EPS Diluted Continuous Ops | 0.04 | 0.08 | 0.03 | -0.01 | -0.08 |
| EPS Diluted Before Non-Recurring Items | 0.07 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $26,252 | $43,667 | $32,314 | $25,933 | $28,861 |